Case reports of its effectiveness in treating metastatic BCC have been published, and it has also been used in patients with advanced cutaneous squamous cell carcinoma, a disease responsible for over 15,000 deaths per year, with promising results
Adoption is constrained by separate program ownership and the difficulty of linking support activity to sustained treatment value
Tell your prescribing clinician about persistent vomiting, dehydration, dizziness, weakness, very rapid weight loss, severe constipation, or inability to meet basic nutrition
For general wellness and daily energy support, a moderate l carnitine dosage per day of 500 to 2,000 mg is typically sufficient